Darigabat, CAS [[1614245-70-3]]

Produktübersicht

• Artikelname: Darigabat, CAS [[1614245-70-3]]
• Artikelnummer: MCE-HY-120874
• Hersteller Artikelnummer: HY-120874
• Alternativnummer: MCE-HY-120874-10MMX1ML,MCE-HY-120874-25MG,MCE-HY-120874-100MG,MCE-HY-120874-5MG,MCE-HY-120874-50MG,MCE-HY-120874-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: PF-06372865, CVL-865

Produktbeschreibung

Darigabat (PF-06372865) is an orally active, alpha2/alpha3/alpha5 subtype-selective GABAA positive allosteric modulator (PAM). Darigabat is a high affinity ligand at GABAA receptors containing alpha1/alpha2/alpha3/alpha5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for alpha2, alpha1 PAM, alpha2 PAM, respectively), with low affinity for alpha4/alpha6 subunits. Darigabat can across the blood-brain barrier (BBB). Darigabat has anxiolytic activity and has the potential for epilepsy[1].

Produkteigenschaften

• Molekulargewicht: 440.49
• Reinheit: 99.29
• CAS Nummer: [1614245-70-3]
• Formel: C22H21FN4O3S
• Target-Kategorie: GABA Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound